Plain-English translation of NCT05674396 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a newer, faster type of radiation therapy called stereotactic body radiotherapy (SBRT) works as well as standard radiation therapy for treating head and neck squamous cell carcinoma in patients who cannot have curative treatment. SBRT delivers radiation in 3 to 5 sessions instead of many sessions over weeks, potentially making treatment faster and more convenient. The study will compare how well each approach relieves pain and symptoms, and which one helps patients feel better overall.
Many patients with advanced head and neck cancer are not healthy enough for surgery or aggressive chemotherapy, so doctors focus on treating symptoms and improving quality of life. This newer radiation approach might offer the same benefits in much less time, reducing the burden on patients who are already facing a serious illness.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the newer SBRT radiation (3 to 5 sessions) or standard radiation therapy (more sessions over several weeks). You'll have visits before treatment to examine your tumor, take imaging scans, and assess your pain and symptoms. Throughout and after treatment, you'll have follow-up appointments where doctors check how you're doing, measure any changes in your symptoms, and ask about your quality of life.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
United States